Nursing and Midwifery Studies, 6 (4), 149
Some studies suggest that high levels of L-carnitine may raise the long-term risks of cardiovascular diseases, though more research is necessary
Wegovy to reduce cardiovascular risk was given Priority Review status and seven months after Novos alternative-fact-filled company announcement the FDA approved Wegovy (the weight loss dose of Semaglutide) for Adults with overw*itght and ob*sity and existing heart disease. This is a much, much bigger group of people than were actually shown to have even the 1.5% reduction in the composite of cardiovascular events
Retrieved 11 October 2015
At-Home Treatment : Professional dermaplaning is recommended over at-home treatments to minimize risks of cuts, scarring, and infection
While most prescription drugs carry the risk of causing side effects, a new study examines the possibility that GLP-1 receptor agonists increase a users risk for certain mental health conditions or even suicide